The Vermont Statutes Online

Title 28 : Public Institutions and Corrections

Chapter 011 : Supervision of Adult Inmates at the Correctional Facilities

Subchapter 003 : Care of Inmates

• § 801b. Medication-assisted treatment in correctional facilities

  (a) If an inmate receiving medication-assisted treatment prior to entering the correctional facility continues to receive medication prescribed in the course of medication-assisted treatment pursuant to section 801 of this title, the inmate shall be authorized to receive that medication for as long as medically necessary.

  (b)(1) If at any time an inmate screens positive as having an opioid use disorder, the inmate may elect to commence buprenorphine-specific medication-assisted treatment if it is deemed medically necessary by a provider authorized to prescribe buprenorphine. The inmate shall be authorized to receive the medication as soon as possible and for as long as medically necessary.

  (2) Nothing in this subsection shall prevent an inmate who commences medication-assisted treatment while in a correctional facility from transferring from buprenorphine to methadone if:

  (A) methadone is deemed medically necessary by a provider authorized to prescribe methadone; and

  (B) the inmate elects to commence methadone as recommended by a provider authorized to prescribe methadone.

  (c) The licensed practitioner who makes the clinical judgment to discontinue a medication shall cause the reason for the discontinuance to be entered into the inmate’s medical record, specifically stating the reason for the discontinuance. The inmate shall be provided, both orally and in writing, with a specific explanation of the decision to discontinue the medication and with notice of the right to have his or her community-based prescriber notified of the decision. If the inmate provides signed authorization, the Department shall notify the community-based prescriber in writing of the decision to discontinue the medication.

  (d)(1) As part of reentry planning, the Department shall commence medication-assisted treatment prior to an inmate’s release if:

  (A) the inmate screens positive for an opioid use disorder;

  (B) medication-assisted treatment is medically necessary; and

  (C) the inmate elects to commence medication-assisted treatment.

  (2) If medication-assisted treatment is indicated and despite best efforts induction is not possible prior to release, the Department shall ensure comprehensive care coordination with a community-based provider.

  (e) Counseling or behavioral therapies shall be provided in conjunction with the use of medication for medication-assisted treatment as provided for in the Department of Health’s “Rule Governing Medication-Assisted Therapy for Opioid Dependence for: (1) Office-Based Opioid Treatment Providers Prescribing Buprenorphine; and (2) Opioid Treatment Providers.” (Added 2017, No. 176 (Adj. Sess.), § 4; amended 2019, No. 72, § E.338.2.)